Common fragile sites and cancer: Targeted cloning by insertional mutagenesis

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 14-27

  Büttel, Isabel ^a   Fechter, Anne ^a   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Breakage fusion bridge cycle; Cancer; Cloned fragile sites; Common fragile sites; FHIT; FRA3B; Gene amplification; Insertional mutagenesis; List of human fragile sites; Preferential integration; Recombination; Targeted cloning

Indexed keywords

CANCER; CARCINOGENESIS; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CONFERENCE PAPER; DNA SEQUENCE; GENE AMPLIFICATION; GENETIC HETEROGENEITY; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN; MARKER GENE; MOLECULAR CLONING;

EID: 14944367013     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (80)

1. DEKABAN, A. 1965. Persisting clone of cells with an abnormal chromosome in a woman previously irradiated. J. Nucl. Med. 6: 740-746.
2. SUTHERLAND, G.R. 1977. Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science 197: 265-266.
3. ABE, S. et al. 1989. Spontaneous chromosome fragility in band 3q21, 11p11, or 11q13 of cultured bone marrow cells from two patients with hematologic disorders. Cancer Genet. Cytogenet. 40: 47-53.
4. DAR, H. et al. 1995. New heritable fragile site with spontaneous expression at 1q41. Am. J. Med. Genet. 55: 145-146.
5. GOLLIN, S.M. et al. 1986. Spontaneous expression of fra(11)(q23) in a patient with Ewing's sarcoma and t(11;22)(q23;q11). Cancer Genet. Cytogenet. 20: 331-339.
6. LUKUSA, T. et al. 1991. "Spontaneous" FRA16B is a hot spot for sister chromatid exchanges. Hum. Genet. 87: 583-586.
7. MATZNER, I., L. SAVELYEVA & M. SCHWAB. 2003. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line. Cancer Lett. 189: 207-219.
8. MIGUEZ, L. et al. 1991. Spontaneous chromosome fragility in chorionic villus cells. Early Hum. Dev. 26: 93-99.
9. TAYLOR, A.M. & S. BUNDEY. 1983. Spontaneous expression of the chromosome fragile site fra(10)(q25). Am. J. Hum. Genet. 35: 123-125.
10. HECHT, F. et al. 1988. New common fragile sites. Cancer Genet. Cytogenet. 33: 1-9.
11. MUSIO, A. & I. SBRANA. 1997. Aphidicolin-sensitive specific common fragile sites: a biomarker of exposure to pesticides. Environ. Mol. Mutagen. 29: 250-255.
12. SUTHERLAND, G.R. 1991. Chromosomal fragile sites. Genet. Anal. Tech. Appl. 8: 161-166.
13. SIMONIC, I. & G.S. GERICKE. 1996. The enigma of common fragile sites. Hum. Genet. 97: 524-531.
14. LIEHR, T. et al. 2001. Regional localization of 10 mariner transposon-like ESTs by means of FISH-evidence for a correlation with fragile sites. Mamm. Genome 12: 326-328.
15. SBRANA, I. et al. 1998. Common fragile sites on human chromosomes represent transcriptionally active regions: evidence from camptothecin. Hum. Genet. 102: 409-414.
16. MURANO, I., A. KUWANO & T. KAJII. 1989. Fibroblast-specific common fragile sites induced by aphidicolin. Hum. Genet. 83: 45-48.
17. SUTHERLAND, G.R., E. BAKER & R.I. RICHARDS. 1998. Fragile sites still breaking. Trends Genet. 14: 501-506.
18. BERGER, R., C.D. BLOOMFIELD & G.R. SUTHERLAND. 1985. Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. Cytogenet. Cell Genet. 40: 490-535.
19. GLOVER, T.W. 1998. Instability at chromosomal fragile sites. Recent Results Cancer Res. 154: 185-199.
20. SUTHERLAND, G.R. & R.I. RICHARDS. 1995. The molecular basis of fragile sites in human chromosomes. Curr. Opin. Genet. Dev. 5: 323-327.
21. GLOVER, T.W. et al. 1984. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67: 136-142.
22. BAN, S., J.B. COLOGNE & K. NERIISHI. 1995. Effect of radiation and cigarette smoking on expression of FUdR- inducible common fragile sites in human peripheral lymphocytes. Mutat... Res. 334: 197-203.
23. HUEBNER, K. et al. 1998. The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet. 32: 7-31.
24. HUEBNER, K. & C.M. CROCE. 2001. FRA3B and other common fragile sites: the weakest links. Nat. Rev. Cancer 1: 214-221.
25. CALLAHAN, G. et al. 2003. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22: 590-601.
26. ZLOTORYNSKI, E. et al. 2003. Molecular basis for expression of common and rare fragile sites. Mol. Cell Biol. 23: 7143-7151.
27. YUNIS, J.J., A.L. SORENG & A.E. BOWE. 1987. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1: 59-69.
28. RUIZ-HERRERA, A. et al. 2002. Fragile sites in human and Macaca fascicularis chromosomes are breakpoints in chromosome evolution. Chromosome Res. 10: 33-44.
29. DJALALI, M. et al. 1987. A comparative mapping study of fragile sites in the human and murine genomes. Hum. Genet. 77: 157-162.
30. KRUMMEL, K.A. et al. 2002. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1. Genes Chromosomes Cancer 34: 154-167.
31. MIRO, R. et al. 1987. Fragile sites, chromosome evolution, and human neoplasia. Hum. Genet. 75: 345-349.
32. YUNIS, J.J. & A.L. SORENG. 1984. Constitutive fragile sites and cancer. Science 226: 1199-1204.
33. SCHMID, M. et al. 1985. Evolutionary conservation of fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in man, gorilla, and chimpanzee. Hum Genet. 71: 342-350.
34. SHIRAISHI, T. et al. 2001. Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit. Proc. Natl. Acad. Sci. USA 98: 5722-5727.
35. GLOVER, T.W., J. COYLE-MORRIS & R. MORGAN. 1986. Fragile sites: overview, occurrence in acute nonlymphocytic leukemia and effects of caffeine on expression. Cancer Genet. Cytogenet. 19: 141-150.
36. LE BEAU, M.M. et al. 1998. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction. Hum Mol Genet. 7: 755-761.
37. WANG, L. et al. 1999. Allele-specific late replication and fragility of the most active common fragile site, FRA3B. Hum. Mol. Genet. 8: 431-437.
38. HELLMAN, A. et al. 2000. Replication delay along FRA7H, a common fragile site on human chromosome 7, leads to chromosomal instability. Mol. Cell Biol. 20: 4420-4427.
39. MISHMAR, D. et al. 1998. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc. Natl. Acad. Sci. USA 95: 8141-8146.
40. MIMORI, K. et al. 1999. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc. Natl. Acad. Sci. USA 96: 7456-7461.
41. MORELLI, C. et al. 2002. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene 21: 7266-7276.
42. RIED, K. et al. 2000. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet. 9: 1651-1663.
43. CASPER, A.M. et al. 2002. ATR regulates fragile site stability. Cell 111: 779-789.
44. Guo, Z. et al. 2000. Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 14: 2745-2756.
45. CLIBY, W.A. et al. 1998. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J. 17: 159-169.
46. HEKMAT-NEJAD, M. et al. 2000. Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint. Curr. Biol. 10: 1565-1573.
47. CIMPRICH, K. A. 2003. Fragile sites: breaking up over a slowdown. Curr. Biol. 13: R231-233.
48. GLOVER, T.W. & C.K. STEIN. 1988. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43: 265-273.
49. PAZ-Y-MINO, C. et al. 1997. Comparative study of chromosome aberrations induced with aphidicolin in women affected by breast cancer and cervix uterine cancer. Cancer Genet. Cytogenet. 94: 120-124.
50. DHILLON, V.S., S.A. HUSAIN & G.N. RAY. 2003. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients. Terat. Carcin. Mutagen. Suppl 1: 35-45.
51. EGELI, U. et al. 2000. The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites. Head Neck 22: 591-598.
52. SUNDARESHAN, T.S. & M. AUGUSTUS. 1995. Expression of common fragile sites in lymphocytes of Wilms tumor in patients, their parents, and siblings. Cancer Genet. Cytogenet. 84: 51-55.
53. VERNOLE, P. et al. 1988. Common fragile sites and human cancer: a study on lymphocytes from neuroblastoma patients. Cancer Genet. Cytogenet. 36: 13-23.
54. MCCLINTOCK, B. 1951. Chromosome organization and genic expression. Cold Spring Harbor Symp. Quant. Biol. 16: 13-47.
55. SAVELYEVA, L. & M. SCHWAB. 2001. Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett. 167: 115-123.
56. TOLEDO, F. et al. 1992. Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J. 11: 2665-2673.
57. COQUELLE, A. et al. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225.
58. KUO, M.T. et al. 1994. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol Cell Biol. 14: 5202-11.
59. GISSELSSON, D. et al. 2000. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc. Natl. Acad. Sci. USA 97: 5357-5362.
60. HELLMAN, A. et al. 2002. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell. 1: 89-97.
61. CIULLO, M. et al. 2002. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum. Mol. Genet. 11: 2887-2894.
62. CANNIZZARO, L.A. et al. 1988. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet. Cytogenet. 33: 93-98.
63. POPESCU, N.C. & J.A. DIPAOLO. 1989. Preferential sites for viral integration on mammalian genome. Cancer Genet. Cytogenet. 42: 157-171.
64. POPESCU, N.C., D. ZIMONJIC & J.A. DIPAOLO. 1990. Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Hum. Genet. 84: 383-386.
65. THORLAND, E.C. et al. 2003. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225-1237.
66. THORLAND, E.C. et al. 2000. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 60: 5916-5921.
67. FERBER, M.J. et al. 2003. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 22: 7233-42.
68. RIVADENEIRA, E. D. et al. 1998. Sites of recombinant adeno-associated virus integration. Int. J. Oncol. 12: 805-810.
69. LIMONGI, M.Z., F. PELLICCIA & A. ROCCHI. 2003. Characterization of the human common fragile site FRA2G. Genomics 81: 93-97.
70. RASSOOL, F.V. et al. 1996. Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics 35: 109-117.
71. RASSOOL, F.V. et al. 1991. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc. Natl. Acad. Sci. USA 88: 6657-6661.
72. WILKE, C.M. et al. 1994. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics 22: 319-326.
73. ZIMONJIC, D. B. et al. 1997. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Cancer Res. 57: 1166-1170.
74. INOUE, H. et al. 1997. Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA 94: 14584-14589.
75. HUANG, H. et al. 1998. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene 16: 2311-2319.
76. ZENKLUSEN, J.C. et al. 2000. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene 19: 1729-1733.
77. KRUMMEL, K.A. et al. 2000. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations. Genomics 69: 37-46.
78. MANGELSDORF, M. et al. 2000. Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res. 60: 1683-1689.
79. ARLT, M.F. et al. 2002. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 33: 82-92.
80. HAN, S.Y., T. DRUCK & K. HUEBNER. 2003. Candidate tumor suppressor genes at FRA7G are coamplified with MET and do not suppress malignancy in a gastric cancer. Genomics 81: 105-107.